Novel glucagon receptor antagonists are currently being investigated in clinical trials (Petersen and Sullivan 2001; Christensen et al. 2011; Engel et al. 2011a,b) and could theoretically be used in the future to control acute hyperglycemia after trauma and hemorrhage. This evidence concerns the gene GCGR and Hyperglycemia.